207 results
Page 2 of 11
8-K
EX-99.1
0rzqi4vz82
7 Aug 23
FibroGen Reports Second Quarter 2023 Financial Results
4:06pm
8-K
EX-10.2
aq8f62zw
25 Jul 23
FibroGen Announces Leadership Transition
8:32am
8-K
76f75dft3v3
9 Jun 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
EX-99.1
vsfzd2bb7n1l rk0
18 May 23
FibroGen Announces Positive Topline Results from China Pivotal Phase 3 Clinical Trial of Roxadustat for the Treatment of Chemotherapy Induced Anemia
7:35am
8-K
EX-99.1
fe9zeya 7oo77uesj
8 May 23
FibroGen Reports First Quarter 2023 Financial Results
4:06pm
DEFA14A
9l4flxubix7z333aic1z
27 Apr 23
Additional proxy soliciting materials
4:10pm
8-K
EX-99.1
hmp240a mb
7 Nov 22
FibroGen Reports Third Quarter 2022 Financial Results
4:06pm
S-8
EX-23.1
oh8xj 2kuvjs
8 Aug 22
Registration of securities for employees
5:22pm
S-8
i25 2qf8lafmbutr
8 Aug 22
Registration of securities for employees
5:22pm
S-3ASR
EX-23.1
ptmej2883mj6f
8 Aug 22
Automatic shelf registration
5:12pm
S-3ASR
EX-1.2
luxg32dyzi7jtkts227
8 Aug 22
Automatic shelf registration
5:12pm
S-3ASR
um05i dqf9
8 Aug 22
Automatic shelf registration
5:12pm